301 related articles for article (PubMed ID: 15768382)
1. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for Glanzmann's thrombasthenia.
Johnson A; Goodall AH; Downie CJ; Vellodi A; Michael DP
Bone Marrow Transplant; 1994 Jul; 14(1):147-50. PubMed ID: 7951102
[TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for children with Glanzmann thrombasthenia.
Connor P; Khair K; Liesner R; Amrolia P; Veys P; Ancliff P; Mathias M
Br J Haematol; 2008 Mar; 140(5):568-71. PubMed ID: 18205861
[TBL] [Abstract][Full Text] [Related]
5. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases.
Porcelijn L; Huiskes E; Maatman R; de Kreuk A; de Haas M
Vox Sang; 2008 Nov; 95(4):324-30. PubMed ID: 19138263
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation in Glanzmann thrombasthenia complicated by platelet alloimmunization.
Wiegering V; Winkler B; Langhammer F; Wölfl M; Wirbelauer J; Sauer K; Kobsar A; Meyer T; Strauss A; Bakchoul T; Eyrich M; Schlegel PG
Klin Padiatr; 2011 May; 223(3):173-5. PubMed ID: 21567370
[TBL] [Abstract][Full Text] [Related]
7. Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia.
Kitko CL; Levine JE; Matthews DC; Carpenter PA
Pediatr Transplant; 2011 May; 15(3):e42-6. PubMed ID: 19849809
[TBL] [Abstract][Full Text] [Related]
8. Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe glanzmann thrombasthenia.
Miller W; Dunn A; Chiang KY
J Pediatr Hematol Oncol; 2009 Jun; 31(6):437-9. PubMed ID: 19648793
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
Horn B; Baxter-Lowe LA; Englert L; McMillan A; Quinn M; Desantes K; Cowan M
Bone Marrow Transplant; 2006 Feb; 37(3):263-9. PubMed ID: 16327813
[TBL] [Abstract][Full Text] [Related]
10. Type I Glanzmann thrombasthenia: most common subtypes in North Indians.
Kannan M; Ahmed RP; Jain P; Kumar R; Choudhry VP; Saxena R
Am J Hematol; 2003 Oct; 74(2):139-41. PubMed ID: 14508803
[TBL] [Abstract][Full Text] [Related]
11. Glanzmann's thrombasthenia: updated.
Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
[TBL] [Abstract][Full Text] [Related]
12. First description of an IgM monoclonal antibody causing α
Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry.
Giannini S; Mezzasoma AM; Guglielmini G; Rossi R; Falcinelli E; Gresele P
Cytometry B Clin Cytom; 2008 May; 74(3):194-9. PubMed ID: 18200593
[TBL] [Abstract][Full Text] [Related]
15. Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation.
Niemeyer GP; Boudreaux MK; Goodman-Martin SA; Monroe CM; Wilcox DA; Lothrop CD
Exp Hematol; 2003 Dec; 31(12):1357-62. PubMed ID: 14662345
[TBL] [Abstract][Full Text] [Related]
16. Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
Neumeister P; Hiller E; Gawaz M; Holler E; Kolb HJ; Sill H; Pihusch R; Mempel W; Wittmann G; Salat C
Eur J Med Res; 1998 Oct; 3(10):465-9. PubMed ID: 9753703
[TBL] [Abstract][Full Text] [Related]
17. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
[TBL] [Abstract][Full Text] [Related]
18. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
20. Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder.
Tholouli E; Hay CR; O'Gorman P; Makris M
Br J Haematol; 2004 Oct; 127(2):209-13. PubMed ID: 15461628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
